Tuberculosis complicated with liver cirrhosis

Kekkaku

Volumn 81, Issue 7, 2006, Pages 457-465

  Saito, Akira ^a,b   Nagayama, Naohiro ^a   Yagi, Osamitsu ^a   Ohshima, Nobuharu ^a   Tamura, Atsuhisa ^a   Nagai, Hideaki ^a   Akagawa, Shinobu ^a   Kawabe, Yoshiko ^a   Machida, Kazuko ^a   Kurashima, Atsuyuki ^a   Yotsumoto, Hideki ^a  

^a TOKYO NATIONAL HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti tuberculous drug; Drug induced liver dysfunction; Leukopenia; Liver cirrhosis; Side effect; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MORTALITY; TUBERCULOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 33748640369     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Thulstrup AM, Molle I, Svendsen N, et al.: Incidence and prognosis of tuberculosis in patients with cirrhosis of the liver. A Danish nationwide population based study. Epidemiol Infect. 2000; 124: 221-225.
2. Iseman MD: A clinician's guide to tuberculosis. Lippincott Williams & Wilkins, Philadelphia, 123.
3. Castano FL, Vierna SE, Polo JL, et al.: Interleukin-1 in alcoholic cirrhosis of the liver: the influence of nutrition. Eur J Clin Nutr. 1992; 46: 527-533.
4. Ungo JR, Jones D, Ashkin D, et al.: Antituberculosis drug-induced hepatotoxicity: the role of hepatitis C virus and the human immunodeficiency virus. Am J Respir Crit Care Med. 1998; 157: 1871-1876.
5. Yew WW, Lee J, Wong PC, et al.: Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction. Int J Clin Pharm Res. 1992; 12: 173-178.
6. Japanese source
7. Japanese source
8. Japanese source
9. Japanese source
10. Japanese source
11. Japanese source
12. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Disease Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003; 167: 603-662.
13. Japanese source
14. Acocella G, Bonollo L, Garimoldi M, et al.: Kinetics of rifampicin and isoniazid administered alone and in combination to normal subjects and patients with liver disease. Gut. 1972; 13: 47-53.
15. Yew WW: Chemotherapy of tuberculosis: present, future and beyond. In: Clinical tuberculosis. Ed Davies PDD. 3rd ed., Arnold, London, 2003.
16. Japanese source
17. Saigal S, Agarwal SR, Nandeesh HP, et al.: Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: A preliminary report. J Gastroent Hepatol. 2001; 16: 1028-1032.
18. Japanese source
19. Japanese source
20. Ohki I, Dan K, Kuriya S, et al.: A study on the mechanism of anemia and leukopenia in Liver Cirrhosis. Jpn J Med. 1988; 27: 155-159.
21. Japanese source